Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 812-702-1
CAS number: 914918-26-6
The bioaccumulative potential of the substance Paliocolor LC 1057 was assessed in an Weight-of-Evidence approach with several QSAR estimations.
In Article 13 of Regulation (EC) No 1907/2006, it is laid down that information on intrinsic properties of substances may be generated by means other than tests, provided that the conditions set out in Annex XI (of the same Regulation) are met. Furthermore according to Article 25 of the same Regulation testing on vertebrate animals shall be undertaken only as a last resort.
According to Annex XI of Regulation (EC) No 1907/2006 (Q)SAR results can be used if (1) the scientific validity of the (Q)SAR model has been established, (2) the substance falls within the applicability domain of the (Q)SAR model, (3) the results are adequate for the purpose of classification and labeling and/or risk assessment and (4) adequate and reliable documentation of the applied method is provided.
For the assessment of the present compound (Q)SAR results were used. The criteria listed in Annex XI of Regulation (EC) No 1907/2006 are considered to be adequately fulfilled and therefore the endpoint(s) sufficiently covered and suitable for risk assessment.
The single QSAR-models and their results are summarized in the table below.
all mitigating factors applied
Nearest neighbor method; in domain
Does not take biotransformation into account
Arnot-Gobas upper trophic level
Including biotransformation rate estimates
All models show results with low BCF values. However, the results of some models are more reliable than others because the substance is outside of the applicability domain of the respective model or does not consider biotransformation.
The BCF basel-line model integrated in Catalogic is a sophisticated model which takes into account different mitigating factors, i.e. acids, metabolism, phenols, size and water solubility. The compound was inside the parametric and the mechanistic domains of the compound but only 30.77% of the fragments of the target chemical are present in correctly predicted training chemicals. Nevertheless, the result is regarded as reliable and suitable to be used in a weight of evidence approach. With all mitigating factors applied the BCF is determined as 8.32. The biggest influence on the bioaccumulative potential has the size of the molecule which limits the uptake. Metabolism has an influence on bioaccumulation, too.
The average diameter of the molecule calculated by Calalogic is about 27 Angström which is for above the diameter which allows uptake through biological membranes. Even the min. diameter with 19.3 Angström is still above. Therefore, bioaccumulation is unlikely to occur in large extent.
US EPA’s Toxicity Estimation Software Tool (T.E.S.T.) uses five submodels to estimate the BCF of the target chemical. These results are than averaged in the consensus approach to provide a higher reliability. The target compound is inside of the applicability domain of one of the single submodels (nearest neighbor). This model revealed a BCF values of 2.38. The confidence in the estimated BCF values of this single submodel is moderate according to the respective and the external training. Still, only one out of the five methods revealed a result.
US EPA’s EPISuite includes the regression-based estimation by Meylan et al. and the Arnot-Gobas model which takes biotransformation processes into account. The target chemical is within the applicability domain of the regression-based estimation tool and the BCF was predicted with 544. A correction for alkyl chains was applied in the equation used for the estimation. However, this result is not regarded as informative, as biotransformation is not explicitly taken into account. The Arnot-Gobas model predicted BCF values of 1.025 for the upper trophic level. The compound’s molecular weight exceeded the recommended range of the model for calculation of the biotransformation rate (848.82 instead of < 600 g/mol) but is still within the range of the training set. Nevertheless, the result by the Arnot-Gobas model is regarded as suitable as all other domain parameters are fulfilled.
In conclusion the reliable QSAR estimations clearly lead to the conclusion that the substance does not significantly accumulate in organisms.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Ce site web utilise des cookies afin de vous garantir la meilleure expérience possible sur nos sites web.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again